- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 29 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 13 residues within 4Å:- Chain A: S.174, E.176, P.177, V.219, L.226, N.227, N.341, C.342, G.343, C.408, V.409, S.410
- Ligands: NAG.37
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.343
NAG-NAG-BMA-MAN.15: 10 residues within 4Å:- Chain C: S.174, E.176, P.177, L.226, N.227, N.341, C.408, V.409, S.410
- Ligands: NAG-NAG.24
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.176
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.19: 15 residues within 4Å:- Chain C: V.102, N.104, N.113, Y.130, L.132, D.285
- Chain E: E.1, G.26, D.31, D.100, G.101, D.102, Y.104, K.120
- Chain H: E.55
4 PLIP interactions:1 interactions with chain C, 2 interactions with chain E, 1 interactions with chain H- Hydrophobic interactions: C:Y.130
- Hydrogen bonds: E:Y.118, E:K.120, H:E.55
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.28: 11 residues within 4Å:- Chain F: E.176, P.177, L.226, N.227, N.341, C.342, G.343, C.408, V.409, S.410
- Ligands: NAG.48
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:G.343, F:V.409
NAG-NAG-BMA.31: 4 residues within 4Å:- Chain F: V.102, N.113, Y.130, D.285
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.37: 5 residues within 4Å:- Chain A: N.227, P.256, Q.258, N.411
- Ligands: NAG-NAG-BMA-MAN.4
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: T.100, N.101
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: E.55, N.56
- Chain B: S.9
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain A: N.303
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain A: P.264, N.266, I.287, G.288
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain A: N.199, T.201, S.239, E.240
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.319
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.101
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.303, S.357
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: N.199, T.201, S.239, I.242
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain D: N.92, S.94
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain F: N.227, P.256, N.411
- Ligands: NAG-NAG-BMA.28
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain F: N.241, T.243, N.244
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain F: N.319
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain F: E.55, N.56
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain F: K.299, N.303, W.359
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain G: N.118, Y.119
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain G: N.97, R.98, N.99, S.101, E.102
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-07
- Peptides
- Envelope glycoprotein Gp120: ACF
Envelope glycoprotein Gp41: BDG
V033-a.01 heavy chain: E
V033-a.01 light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
EF
IB
BD
FG
JE
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 29 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-07
- Peptides
- Envelope glycoprotein Gp120: ACF
Envelope glycoprotein Gp41: BDG
V033-a.01 heavy chain: E
V033-a.01 light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
EF
IB
BD
FG
JE
HH
L